RE:RE:RE:Somebody rang the alarm bellRiverrow ...Ph. 2 trials cannot be concentrated at only 1 location. It would raise too many doubts about repeatability of the process, if concentrated within the same UHN team.
One of the purposes of these Ph. 2b trials is to demonstrate that a new technology can be applied/executed correctly by a growing number of specialists (urologists in our case) spanned across a wider geography, over and over, with the same rate of success when it comes to execution. Just like the pool of patients will also have to represent an accurate image of the variety of ethnicity of patients that can qualify for such technology.
To ensure urologists of other regions
for this Ph. 2b execute properly, PMH will send its staff to these other locations to ensure proper training. Mass training will occur in Toronto when commercial approval will have been granted.
That's the way this industry (and many others) work. And it makes sense.
_________________
riverrrow - (8/21/2019 8:53:00 AM) RE:RE:Somebody rang the alarm bell Personally I would prefer to see TLT treat all their Canadian patients at one site by one team to ensure consistency even if TLT has to pay all the patients expenses. GLTA.